ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

DCT Board Approves Reissuing Surgical Oncology RFA For Planning, Okays New Recompleting Projects

June 17, 1983

ACCC Members To Lobby, Hear Discussion on Oncology Unit

January 6, 1978

Breast Cancer Patients Track Symptoms With Digital Device

September 25, 2009

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999